TG Therapeutics, Inc. Profile Avatar - Palmy Investing

TG Therapeutics, Inc.

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituxima…
Biotechnology
US, New York [HQ]
TGTX/Financials
Supply · Problems · Premarket · Compliance

Supply Analysis

Supply Analysis
End of TGTX's Analysis
CIK: 1001316 CUSIP: 88322Q108 ISIN: US88322Q1085 LEI: - UEI: -
Secondary Listings
TGTX has no secondary listings inside our databases.